Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Max Neeman International
RESEARCH TRIANGLE PARK, N.C., June 9, 2014 /PRNewswire/ -- Max Neeman International announced today that India's Ministry of Health released new and revised draft guidelines on compensation to be paid for medical management with regards to treatment of any injury related to clinical trial is now aligned with global standards.
The new guidelines on medical management in clinical trial injury states that:
The new amendments will enhance the safety of subjects and ensure adequate care is taken in the event of an injury in clinical trial.
About Max Neeman International
Max Neeman International is a full service CRO with S.E. Asia expertise. Our specialty is that we offer services for the successful conduct of clinical trials for small and mid-sized drug/device and nutraceutical companies in compliance with ICH GCP standards. Max Neeman is ISO certified for Monitoring, Site Management and Data Management Services. Please contact: Ann Vawter - Director, Business & Marketing Max Neeman International P: 919.424.3332 / F: 919.852.5574 Email: email@example.com
©2012 PR Newswire. All Rights Reserved.